장암칼스

비상장계속사업자

CALS Corp.

구연찬

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

장암칼스

Business Reg. No. 1078156217 · CEO 구연찬

I.Investment Overview

Target장암칼스 (1078156217)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명장암칼스
영문명CALS Corp.
대표자구연찬
사업자등록번호1078156217
법인등록번호1101110555536
설립일1987.12.31
종업원수21명

V.Workforce

21

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW427.62021552.32022637.82023673.72024690.12025
영업이익100M KRW8.7202146.5202293202381.7202448.92025
순이익100M KRW13.4202140.9202282.2202393.9202485.82025
Item20252024202320222021
자산총계858.7억원782.2억원737.6억원649.2억원568.1억원
부채총계278.5억원289.5억원368.7억원360.4억원320.2억원
자본총계580.2억원492.7억원368.8억원288.8억원247.9억원
매출액690.1억원673.7억원637.8억원552.3억원427.6억원
영업이익48.9억원81.7억원93억원46.5억원8.7억원
순이익85.8억원93.9억원82.2억원40.9억원13.4억원

VII.Financial Ratios

FY2025 basis

7.09%

영업이익률

12.44%

순이익률

10%

ROA

14.79%

ROE

48.01%

부채비율

67.56%

자기자본비율

VIII.R&D Activity

Fields 화공 > 정밀화학 · 화공 > 화학제품 · 화학 > 유기화학

Keywords 마찰, 고효율, 친환경, 윤활제, 그리스

YearProjectsPapersPatents
2022000
2021102
2020100
2019101
2018132
2017101
2016102
2015200
2014200
2013302
2012342
2011202

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

장암칼스 투심보고서 | Alpha Lenz